- Home
- Investors
- Product portfolio
- Consumer Healthcare products
Consumer Healthcare products
Our principal consumer Healthcare products are in three major areas. An analysis of sales by these areas is set out below:Turnover |
2010 £m |
2009 £m |
2008 £m |
|---|---|---|---|
| OTC medicines | 2,456 | 2.319 | 1,935 |
 |
|||
| Oral care | 1,602 | 1,484 | 1,240 |
|
|||
| Nutritional healthcare | 952 | 851 | 796 |
|
|||
| 5,010 | 4,654 | 3,971 | |
|
|||
Total Consumer Healthcare sales were up 5% to £5.0 billion, significantly exceeding market growth estimated by GSK to be approximately 2%.
Major products, which are not necessarily sold in all markets, are:
Category |
Product |
|---|---|
|
Over-the-counter medicines Analgesics |
Panadol |
|
|
| Dermatologicals | Zovirax Abreva |
|
|
| Nasal dilators | Breathe Right |
|
|
| Gastro-intestinal | Tums Citrucel |
|
|
| Respiratory tract | Contac Beechams |
|
|
| Smoking control | Commit Nicorette (USA only) NicoDerm CQ NiQuitin CQ Nicabate CQ |
|
|
| Natural wellness support | Abtei FiberChoice |
|
|
| Weight control | alli |
|
|
| Oral care | Aquafresh |
|
|
| Nutritional healthcare | Lucozade Ribena Horlicks |
|
|
Over-the-counter medicines
The leading products are Panadol, a widely available paracetamol/acetominophen analgesic; Nicorette gum in the USA; the NicoDerm, NiQuitin CQ and Nicabate range of smoking control products; Tums, a calcium-based antacid; Citrucel laxative; Contac for the treatment of colds; Abtei, a natural medicines and vitamin range; and Zovirax and Abreva for the treatment of cold sores.Recent additions to the portfolio include Breathe Right nasal strips that gently lift open nasal passages to provide better breathing, and FiberChoice daily fibre supplements, through the acquisition of CNS, Inc. in 2006.
In June 2007, the Group launched alli in the USA; alli is an FDA-approved prescription product for obesity management. alli is now available throughout Europe.